Abstract:P414 ASSESSMENT OF THE CHANGE IN ESTIMATED GLOMERULAR FILTRATION RATES IN TELBIVUDINEOR LAMIVUDINE-BASED TRERAPY IN PATIENTS WITH CHRONIC HEPATITIS B J. Sun, J. Cheng, X. Chen, Q. Xie, D. Tan, H. Wang, S. Chen, Y. Yu, H. Tang, J. Niu, J. Sheng, Y. Sun, Q. Ning, M. Wan, X. Bai, G. Shi, H. Ren, M. Xu, X. Dou, J. Shi, J. Jiang, X. Chen, H. Long, M. Wang, H. Zhang, Z. Gao, C. Chen, J. Jiang, H. Ma, J. Jia, J. Hou. Hepatology Unit, Nanfang Hospital, Guangzhou, Beijing Ditan Hospital, Beijing Youan Hospital, Beijing, Ruijin Hospital, Shanghai, Xiangya Hospital, Changsha, Peking University People’s Hospital, Beijing, Ji’nan Infectious Diseases Hospital, Ji’nan, First Hospital of Peking University, Beijing, Huaxi Hospital, Chengdu, No. 1 Hospital Affiliated to Jilin University, Changchun, Zhejiang University 1st Affiliated Hospital, Hangzhou, Tangdu Hospital, Xi’an, Tongji Hospital, Wuhan, Changhai Hospital, Shanghai Huashan Hospital, Shanghai, Chongqing Medical University 2nd Affiliated Hospital, Chongqing, 8th People’s Hospital, Guangzhou, Shengjing Hospital, Shenyang, 6th People’s Hospital, Hangzhou, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangdong General Hospital, Guangzhou, The First People Hospital of Foshan, Foshan, 81st PLA Hospital, Guangzhou, 302nd PLA Hospital, Beijing, Sun Yat-Sen University 3rd Affiliated Hospital, Guangzhou, 85th PLA Hospital, Shanghai, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Beijing Friendship Hospital, Beijing, China E-mail: doctorsunjian@qq.com Background and Aims: Recent pooled analyses of multiple studies of telbivudine in patients with chronic hepatitis B (CHB) demonstrated that telbivudine therapy was associated with a consistent increase of estimated Glomerular Filtration Rates (eGFR). The aim of this study was to validate the effect on eGFR of telbivudineor lamivudine-based therapy in two multi-center, randomized controlled studies in Chinese CHB patients. Methods: 606 and 366 compensated HBeAg positive CHB patients were enrolled in the EFFORT (NCT00962533) and EXPLORE (NCT01088009) studies with similar study design based on ROADMAP concept, receiving telbivudine-based and lamivudinebased therapies for up to 104 weeks, respectively. Adefovir was added to patients per protocol at baseline or week 28, or at virological breakthrough. eGFR was assessed with aMDRD equation.

TangHerb Has No Obvious Impact on the Pharmacokinetics of Efavirenz among HIV Patients

Efifcacy and safety of highly active antiretroviral therapy combined with TangHerb among HIV-infected patients

Effect of Food on the Pharmacokinetics of Tenofovir Amibufenamide: A Phase I, Randomized, Open-Label, Two-Period Crossover Trial in Healthy Adult Subjects

Proteomic study on effect of Tangcao pill on microsome CYP450

The Impact of Highly Active Antiretroviral Treatment on the Blood Profiles of Patients with Acquired Immune Deficiency Syndrome

Pharmacokinetics of Tenofovir Disoproxil Fumarate Tablets in Healthy Volunteers from Western China

The effect of different HAART regimens on liver function and HIV load of HIV infected children with HCV co-infection

Effect of Efavirenz on the Pharmacokinetics of SHR6390 in Healthy Volunteers

Effects of Rifampicin, CYP2B6 and ABCB1 Polymorphisms on Efavirenz Plasma Concentration in Chinese Patients Living with HIV and Tuberculosis.

Pharmacogenomics and Pharmacokinetics of Efavirenz 400 or 600 Mg in 184 Treatment-Naive HIV-infected Patients in China

P414 ASSESSMENT OF THE CHANGE IN ESTIMATED GLOMERULAR FILTRATION RATES IN TELBIVUDINE- OR LAMIVUDINE-BASED TRERAPY IN PATIENTS WITH CHRONIC HEPATITIS B

Minimum Effective Plasma Concentration Of Efavirenz In Treatment-Naive Chinese Hiv-Infected Patients

Interaction of Rifabufin and Efavirenz on Pharmacokinetics in Rats

The Effect of Highly Active Antiretroviral Therapy on Liver Function in Human Immunodeficiency Virus-Infected Pediatric Patients with or Without Hepatitis Virus Co-Infection

Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection

Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults

Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate Versus Emtricitabine and Tenofovir Disoproxil Fumarate As Treatments for Patients with Chronic Hepatitis B

Hiv Drug Resistance And Its Impact On Antiretroviral Therapy In Chinese Hiv-Infected Patients

Clinical Observations on 100 HIV/AIDS Cases Treated with Chinese Herb Aining Granule Plus HAART

Efficacy and safety of Efavirenz 400 mg-based regimens switching from 600 mg-based regimens in people living with HIV with virological suppression in China: a randomized, open-label, non-inferiority study

Efficacy and safety of efavirenz-based regimens in human immunodeficiency virus/hepatitis C virus co-infected patients